You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 167 No. 22, Dec 10/24, 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Aging/ Geriatrics
 •Renal Diseases, Other
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic

Association of Kidney Function and Albuminuria With Cardiovascular Mortality in Older vs Younger Individuals

The HUNT II Study

Stein Hallan, MD, PhD; Brad Astor, MPH, PhD; Solfrid Romundstad, MD, PhD; Knut Aasarød, MD, PhD; Kurt Kvenild, MD; Josef Coresh, MD, PhD

Arch Intern Med. 2007;167(22):2490-2496.

Background  The cardiovascular risk implications of a combined assessment of reduced kidney function and microalbuminuria are unknown. In elderly persons, traditional cardiovascular risk factors are less predictive, and measures of end organ damage, such as kidney disease, may be needed for improved cardiovascular mortality risk stratification.

Methods  The glomerular filtration rate was estimated from calibrated serum creatinine, and the urine albumin-creatinine ratio (ACR) was measured in 3 urine samples in 9709 participants of the second Nord-Trøndelag Health Study (HUNT II), a Norwegian community-based health study, followed for 8.3 years with a 71% participation rate.

Results  An estimated glomerular filtration rate (EGFR) at levels of less than 75 mL/min/1.73 m2 was associated with higher cardiovascular mortality risk, whereas a higher ACR was associated with higher risk with no lower limit. Low EGFR and albuminuria were synergistic cardiovascular mortality risk factors. Compared with subjects with an EGFR greater than 75 mL/min/1.73 m2 and ACR below the sex-specific median who were at the lowest risk, subjects with an EGFR of less than 45 mL/min/1.73 m2 and microalbuminuria had an adjusted incidence rate ratio of 6.7 (95% confidence interval, 3.0-15.1; P < .001). The addition of ACR and EGFR improved traditional risk models: 39% of subjects with intermediate risk were reclassified to low- or high-risk categories with corresponding observed risks that were 3-fold different than the original category. Age-stratified analyses showed that EGFR and ACR were particularly strong risk factors for persons 70 years or older.

Conclusions  Reduced kidney function and microalbuminuria are risk factors for cardiovascular death, independent of each other and traditional risk factors. The combined variable improved cardiovascular risk stratification at all age levels, but particularly in elderly persons where the predictive power of traditional risk factors is attenuated.


Author Affiliations: Departments of Cancer Research and Molecular Medicine (Drs Hallan, Romundstad, and Aasarød) and Community Medicine (Dr Kvenild), Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Medicine, Division of Nephrology, St Olav University Hospital, Trondheim (Drs Hallan, Romundstad, and Aasarød); and Welch Center for Prevention, Epidemiology, and Clinical Research, Department of Epidemiology, Bloomberg School of Public Health, and Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland (Drs Astor and Coresh).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hermann Senator and albuminuria--forgotten pioneering work in the 19th century
Gansevoort and Ritz
Nephrol Dial Transplant 2008;0:gfn741v1-gfn741.
ABSTRACT | FULL TEXT  

Early identification and management of chronic kidney disease: summary of NICE guidance
Crowe et al.
BMJ 2008;337:a1530-a1530.
FULL TEXT  

Reporting eGFR
Bennett
CJASN 2008;3:1561-1562.
FULL TEXT  

Staging of Chronic Kidney Disease: Time for a Course Correction
Bauer et al.
J. Am. Soc. Nephrol. 2008;19:844-846.
ABSTRACT | FULL TEXT  

Statins for people with kidney disease
Clase
BMJ 2008;336:624-625.
FULL TEXT  

Cardiovascular Literature--Beyond Nephrology
Ritz
CJASN 2008;3:317-323.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.